244 related articles for article (PubMed ID: 32460032)
41. Learning from mouse models of MLL fusion gene-driven acute leukemia.
Schwaller J
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
[TBL] [Abstract][Full Text] [Related]
42. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154
[TBL] [Abstract][Full Text] [Related]
43. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
Möhle R; Schittenhelm M; Failenschmid C; Bautz F; Kratz-Albers K; Serve H; Brugger W; Kanz L
Br J Haematol; 2000 Sep; 110(3):563-72. PubMed ID: 10997965
[TBL] [Abstract][Full Text] [Related]
44. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
[TBL] [Abstract][Full Text] [Related]
45. Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.
Chapellier M; Peña-Martínez P; Ramakrishnan R; Eriksson M; Talkhoncheh MS; Orsmark-Pietras C; Lilljebjörn H; Högberg C; Hagström-Andersson A; Fioretos T; Larsson J; Järås M
Haematologica; 2019 Oct; 104(10):2006-2016. PubMed ID: 30819903
[TBL] [Abstract][Full Text] [Related]
46. Internal tandem duplication mutations in FLT3 gene augment chemotaxis to Cxcl12 protein by blocking the down-regulation of the Rho-associated kinase via the Cxcl12/Cxcr4 signaling axis.
Onishi C; Mori-Kimachi S; Hirade T; Abe M; Taketani T; Suzumiya J; Sugimoto T; Yamaguchi S; Kapur R; Fukuda S
J Biol Chem; 2014 Nov; 289(45):31053-65. PubMed ID: 25237195
[TBL] [Abstract][Full Text] [Related]
47. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
[TBL] [Abstract][Full Text] [Related]
48. BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment.
Piya S; Mu H; Bhattacharya S; Lorenzi PL; Davis RE; McQueen T; Ruvolo V; Baran N; Wang Z; Qian Y; Crews CM; Konopleva M; Ishizawa J; You MJ; Kantarjian H; Andreeff M; Borthakur G
J Clin Invest; 2019 May; 129(5):1878-1894. PubMed ID: 30829648
[TBL] [Abstract][Full Text] [Related]
49. Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1α-TAZ Signaling Pathway in Osteoblasts.
Kremer KN; Dudakovic A; Hess AD; Smith BD; Karp JE; Kaufmann SH; Westendorf JJ; van Wijnen AJ; Hedin KE
J Biol Chem; 2015 Dec; 290(49):29478-92. PubMed ID: 26491017
[TBL] [Abstract][Full Text] [Related]
50. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
[TBL] [Abstract][Full Text] [Related]
51. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
Chen L; Chen W; Mysliwski M; Serio J; Ropa J; Abulwerdi FA; Chan RJ; Patel JP; Tallman MS; Paietta E; Melnick A; Levine RL; Abdel-Wahab O; Nikolovska-Coleska Z; Muntean AG
Leukemia; 2015 Jun; 29(6):1290-300. PubMed ID: 25650089
[TBL] [Abstract][Full Text] [Related]
52. Self-Stimulated Photodynamic Nanoreactor in Combination with CXCR4 Antagonists for Antileukemia Therapy.
Zhang Y; Chen L; Fu T; Xu A; Li K; Hao K; Lyu J; Wang Z; Kong F
ACS Appl Mater Interfaces; 2024 May; 16(17):21610-21622. PubMed ID: 38647446
[TBL] [Abstract][Full Text] [Related]
53. CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress.
Zhang Y; Dépond M; He L; Foudi A; Kwarteng EO; Lauret E; Plo I; Desterke C; Dessen P; Fujii N; Opolon P; Herault O; Solary E; Vainchenker W; Joulin V; Louache F; Wittner M
Sci Rep; 2016 Nov; 6():37827. PubMed ID: 27886253
[TBL] [Abstract][Full Text] [Related]
54. [Establishment of AML Mouse Model by Transplantation of Hematopoietic Cells from MLL-AF9 Transgenic Mice].
Long WY; Shen X; Xing S; Xiong GL; Wang HG; Yu ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1369-1374. PubMed ID: 34627412
[TBL] [Abstract][Full Text] [Related]
55. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
56. [Research Advance of CXCR4 Inhibitors in the Treatment of Acute Myeloid Leukemia--Review].
Liang JP; Li W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1355-1359. PubMed ID: 34362530
[TBL] [Abstract][Full Text] [Related]
57. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
[TBL] [Abstract][Full Text] [Related]
58. CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis.
Braun M; Qorraj M; Büttner M; Klein FA; Saul D; Aigner M; Huber W; Mackensen A; Jitschin R; Mougiakakos D
Leukemia; 2016 Aug; 30(8):1788-92. PubMed ID: 26952837
[No Abstract] [Full Text] [Related]
59. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
[TBL] [Abstract][Full Text] [Related]
60. Tissue-Nonspecific Alkaline Phosphatase Is Required for MC3T3 Osteoblast-Mediated Protection of Acute Myeloid Leukemia Cells from Apoptosis.
Sterner RM; Kremer KN; Dudakovic A; Westendorf JJ; van Wijnen AJ; Hedin KE
J Immunol; 2018 Aug; 201(3):1086-1096. PubMed ID: 29914885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
